{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:49:01Z","timestamp":1792162141748,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12846-z","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:21:23Z","timestamp":1792160483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ursolic acid in cancer therapy: a review of signaling pathways and apoptotic mechanisms"],"prefix":"10.1007","volume":"53","author":[{"given":"Shipra","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6090-8809","authenticated-orcid":false,"given":"Baljinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"12846_CR1","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fphar.2019.01614","volume":"10","author":"AS Choudhari","year":"2020","unstructured":"Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O (2020) Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front Pharmacol 10:1614. https:\/\/doi.org\/10.3389\/fphar.2019.01614","journal-title":"Front Pharmacol"},{"issue":"11","key":"12846_CR2","doi-asserted-by":"publisher","first-page":"20614","DOI":"10.3390\/molecules201119721","volume":"20","author":"\u0141 Wo\u017aniak","year":"2015","unstructured":"Wo\u017aniak \u0141, Sk\u0105pska S, Marsza\u0142ek K (2015) Ursolic acid\u2013a pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules 20(11):20614\u201320641. https:\/\/doi.org\/10.3390\/molecules201119721","journal-title":"Molecules"},{"issue":"1","key":"12846_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s43094-025-00796-5","volume":"11","author":"SM Bakry","year":"2025","unstructured":"Bakry SM, El-Shiekh RA, Hatem S, Mandour AA, El-Dessouki AM, Bishr A, Elhusseiny SM (2025) Therapeutic applications of ursolic acid: a comprehensive review and utilization of predictive tools. Future J Pharm Sci 11(1):48","journal-title":"Future J Pharm Sci"},{"key":"12846_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.lfs.2016.01.017","volume":"146","author":"D Kashyap","year":"2016","unstructured":"Kashyap D, Tuli HS, Sharma AK (2016) Ursolic acid (UA): a metabolite with promising therapeutic potential. Life Sci 146:201\u2013213","journal-title":"Life Sci"},{"key":"12846_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ejmech.2015.03.051","volume":"95","author":"SX Hua","year":"2015","unstructured":"Hua SX, Huang RZ, Ye MY, Pan YM, Yao GY, Zhang Y, Wang HS (2015) Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents. Eur J Med Chem 95:435\u2013452","journal-title":"Eur J Med Chem"},{"issue":"15","key":"12846_CR6","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/molecules24152751","volume":"24","author":"S Mlala","year":"2019","unstructured":"Mlala S, Oyedeji AO, Gondwe M, Oyedeji OO (2019) Ursolic acid and its derivatives as bioactive agents. Molecules 24(15):2751. https:\/\/doi.org\/10.3390\/molecules24152751","journal-title":"Molecules"},{"key":"12846_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.4236\/jct.2019.1010073","volume":"10","author":"E Scherrer","year":"2019","unstructured":"Scherrer E, Valadares Y, Alves C, Ferreira G, Le\u00e3o M, Soares J, Silva F, Carli A, Cardoso O Jr, Machado F, Castro S (2019) Ursolic acid derivatives induced apoptosis and reduces the NF-\u03baB in human lung adenocarcinoma cells. J Cancer Ther 10:863\u2013876. https:\/\/doi.org\/10.4236\/jct.2019.1010073","journal-title":"J Cancer Ther"},{"key":"12846_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9980949","author":"J Zhao","year":"2021","unstructured":"Zhao J, Leng P, Xu W, Sun JL, Ni BB, Liu GW (2021) Investigating the multitarget pharmacological mechanism of ursolic acid acting on colon cancer: a network pharmacology approach. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2021\/9980949","journal-title":"Evid Based Complement Alternat Med"},{"issue":"28","key":"12846_CR9","doi-asserted-by":"publisher","first-page":"7404","DOI":"10.1021\/acs.jafc.0c03202","volume":"68","author":"X Zhang","year":"2020","unstructured":"Zhang X, Li T, Gong ES, Liu RH (2020) Antiproliferative activity of ursolic acid in MDA-MB-231 human breast cancer cells through Nrf2 pathway regulation. J Agric Food Chem 68(28):7404\u20137415","journal-title":"J Agric Food Chem"},{"key":"12846_CR10","doi-asserted-by":"crossref","unstructured":"Guo, W., Xu, B., Wang, X., Zheng, B., Du, J., & Liu, S. (2020). The analysis of the anti-tumor mechanism of ursolic acid using connectively map approach in breast cancer cells line MCF-7. Cancer Management and Research, 3469\u20133476.","DOI":"10.2147\/CMAR.S241957"},{"issue":"4","key":"12846_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3746\/pnf.2021.26.4.434","volume":"26","author":"GD Kim","year":"2021","unstructured":"Kim GD (2021) Ursolic acid decreases the proliferation of MCF-7 cell-derived breast cancer stem-like cells by modulating the ERK and PI3K\/AKT signaling pathways. Prev Nutr Food Sci 26(4):434","journal-title":"Prev Nutr Food Sci"},{"key":"12846_CR12","first-page":"102","volume":"12","author":"N Kaewthawee","year":"2013","unstructured":"Kaewthawee N, Brimson S (2013) The effects of ursolic acid on cytokine production via the MAPK pathways in leukemic T-cells. EXCLI J 12:102","journal-title":"EXCLI J"},{"issue":"21","key":"12846_CR13","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1021\/acs.jafc.6b00542","volume":"64","author":"CC Wu","year":"2016","unstructured":"Wu CC, Cheng CH, Lee YH, Chang IL, Chen HY, Hsieh CP, Chueh PJ (2016) Ursolic acid triggers apoptosis in human osteosarcoma cells via caspase activation and the ERK1\/2 MAPK pathway. J Agric Food Chem 64(21):4220\u20134226","journal-title":"J Agric Food Chem"},{"issue":"3","key":"12846_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.etap.2014.03.011","volume":"37","author":"JQ Ma","year":"2014","unstructured":"Ma JQ, Ding J, Zhang L, Liu CM (2014) Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK\/NF-\u03baB pathway. Environ Toxicol Pharmacol 37(3):975\u2013983","journal-title":"Environ Toxicol Pharmacol"},{"issue":"7","key":"12846_CR15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.intimp.2008.02.013","volume":"8","author":"KA Manu","year":"2008","unstructured":"Manu KA, Kuttan G (2008) Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-\u03baB mediated activation of bcl-2 in B16F\u201310 melanoma cells. Int Immunopharmacol 8(7):974\u2013981","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"12846_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/ijc.25044","volume":"127","author":"Y Li","year":"2010","unstructured":"Li Y, Xing D, Chen Q, Chen WR (2010) Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-\u03baB using ursolic acid. Int J Cancer 127(2):462\u2013473","journal-title":"Int J Cancer"},{"issue":"2","key":"12846_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3892\/or.2012.1827","volume":"28","author":"J Li","year":"2012","unstructured":"Li J, Liang X, Yang X (2012) Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K\/Akt\/NF-\u03baB pathways. Oncol Rep 28(2):501\u2013510","journal-title":"Oncol Rep"},{"issue":"5","key":"12846_CR18","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3892\/mmr.2013.1364","volume":"7","author":"L Gai","year":"2013","unstructured":"Gai L, Cai N, Wang L, Xu X, Kong X (2013) Ursolic acid induces apoptosis via Akt\/NF-\u03baB signaling suppression in T24 human bladder cancer cells. Mol Med Rep 7(5):1673\u20131677","journal-title":"Mol Med Rep"},{"issue":"4","key":"12846_CR19","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.3892\/mmr.2015.4053","volume":"12","author":"V Aguiriano-Moser","year":"2015","unstructured":"Aguiriano-Moser V, Svejda B, Li ZX, Sturm S, Stuppner H, Ingolic E, H\u00f6ger HARALD, Siegl VERONIKA, Meier-Allard NATHALIE, Sadjak ANTON, Pfragner R (2015) Ursolic acid from Trailliaedoxa gracilis induces apoptosis in medullary thyroid carcinoma cells. Mol Med Rep 12(4):5003\u20135011","journal-title":"Mol Med Rep"},{"issue":"12","key":"12846_CR20","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1080\/09168451.2020.1813543","volume":"84","author":"M Cao","year":"2020","unstructured":"Cao M, Xiao D, Ding X (2020) The anti-tumor effect of ursolic acid on papillary thyroid carcinoma via suppressing Fibronectin-1. Biosci Biotechnol Biochem 84(12):2415\u20132424","journal-title":"Biosci Biotechnol Biochem"},{"key":"12846_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153726","volume":"92","author":"L Yuan","year":"2021","unstructured":"Yuan L, Zhang L, Yao N, Wu L, Liu J, Liu F, Zhang H, Hu X, Xiong Y, Xia C (2021) Upregulation of UGT1A1 expression by ursolic acid and oleanolic acid via the inhibition of the PKC\/NF-\u03baB signaling pathway. Phytomedicine 92:153726","journal-title":"Phytomedicine"},{"issue":"9","key":"12846_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/1541-7786.MCR-06-0348","volume":"5","author":"AK Pathak","year":"2007","unstructured":"Pathak AK, Bhutani M, Nair AS, Ahn KS, Chakraborty A, Kadara H, Guha S, Sethi G, Aggarwal BB (2007) Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Mol Cancer Res MCR 5(9):943\u2013955. https:\/\/doi.org\/10.1158\/1541-7786.MCR-06-0348","journal-title":"Mol Cancer Res MCR"},{"issue":"2","key":"12846_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3892\/ijo.2017.4035","volume":"51","author":"T Liu","year":"2017","unstructured":"Liu T, Ma H, Shi W, Duan J, Wang Y, Zhang C, Li C, Lin J, Li S, Lv J, Lin L (2017) Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma. Int J Oncol 51(2):555\u2013562. https:\/\/doi.org\/10.3892\/ijo.2017.4035","journal-title":"Int J Oncol"},{"key":"12846_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.622212","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang M, Hu C, Cao Y, Liang W, Yang X, Xiao T (2021) Ursolic acid regulates cell cycle and proliferation in colon adenocarcinoma by suppressing cyclin B1. Front Pharmacol 11:622212","journal-title":"Front Pharmacol"},{"issue":"6","key":"12846_CR25","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/cells9061451","volume":"9","author":"S Bose","year":"2020","unstructured":"Bose S, Banerjee S, Mondal A, Chakraborty U, Pumarol J, Croley CR, Bishayee A (2020) Targeting the JAK\/STAT signaling pathway using phytocompounds for cancer prevention and therapy. Cells 9(6):1451","journal-title":"Cells"},{"issue":"3","key":"12846_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9030297","volume":"9","author":"DY Kang","year":"2021","unstructured":"Kang DY, Sp N, Lee JM, Jang KJ (2021) Antitumor effects of ursolic acid through mediating the inhibition of STAT3\/PD-L1 signaling in non-small cell lung cancer cells. Biomedicines 9(3):297. https:\/\/doi.org\/10.3390\/biomedicines9030297","journal-title":"Biomedicines"},{"issue":"1","key":"12846_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010114","volume":"20","author":"K Kim","year":"2018","unstructured":"Kim K, Shin EA, Jung JH, Park JE, Kim DS, Shim BS, Kim SH (2018) Ursolic acid induces apoptosis in colorectal cancer cells partially via upregulation of MicroRNA-4500 and inhibition of JAK2\/STAT3 phosphorylation. Int J Mol Sci 20(1):114","journal-title":"Int J Mol Sci"},{"issue":"4","key":"12846_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT (2017) The PI3K pathway in human disease. Cell 170(4):605\u2013635. https:\/\/doi.org\/10.1016\/j.cell.2017.07.029","journal-title":"Cell"},{"issue":"19","key":"12846_CR29","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.3390\/molecules24193444","volume":"24","author":"NS Castrej\u00f3n-Jim\u00e9nez","year":"2019","unstructured":"Castrej\u00f3n-Jim\u00e9nez NS, Leyva-Paredes K, Baltierra-Uribe SL, Castillo-Cruz J, Campillo-Navarro M, Hern\u00e1ndez-P\u00e9rez AD, Luna-Angulo AB, Chac\u00f3n-Salinas R, Coral-V\u00e1zquez RM, Estrada-Garc\u00eda I, S\u00e1nchez-Torres LE, Torres-Torres C, Garc\u00eda-P\u00e9rez BE (2019) Ursolic and oleanolic acids induce mitophagy in A549 human lung cancer cells. Molecules 24(19):3444. https:\/\/doi.org\/10.3390\/molecules24193444","journal-title":"Molecules"},{"issue":"50","key":"12846_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036602","volume":"102","author":"Q Zheng","year":"2023","unstructured":"Zheng Q, Wang X, Gao T, Zhang B, Zhao N, Du R, Zhao Z (2023) Exploring the pharmacological and molecular mechanisms of Salvia chinensis Benth in colorectal cancer: a network pharmacology and molecular docking study. Medicine 102(50):e36602. https:\/\/doi.org\/10.1097\/MD.0000000000036602","journal-title":"Medicine"},{"issue":"2","key":"12846_CR31","first-page":"750","volume":"25","author":"W Lin","year":"2020","unstructured":"Lin W, Ye H (2020) Anticancer activity of ursolic acid on human ovarian cancer cells via ROS and MMP mediated apoptosis, cell cycle arrest and downregulation of PI3K\/AKT pathway. J BUON 25(2):750\u2013756","journal-title":"J BUON"},{"issue":"7","key":"12846_CR32","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1142\/S0192415X2450085X","volume":"52","author":"M Xu","year":"2024","unstructured":"Xu M, Li X, Yuan C, Zhu T, Wang M, Zhu Y, Duan Y, Yao J, Luo B, Wang Z, Yin S, Zhao Y (2024) Ursolic acid inhibits glycolysis of ovarian cancer via KLF5\/PI3K\/AKT signaling pathway. Am J Chin Med 52(7):2211\u20132231. https:\/\/doi.org\/10.1142\/S0192415X2450085X","journal-title":"Am J Chin Med"},{"issue":"24","key":"12846_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249409","volume":"21","author":"NR Lee","year":"2020","unstructured":"Lee NR, Meng RY, Rah SY, Jin H, Ray N, Kim SH, Park BH, Kim SM (2020) Reactive oxygen species-mediated autophagy by ursolic acid inhibits growth and metastasis of esophageal cancer cells. Int J Mol Sci 21(24):9409","journal-title":"Int J Mol Sci"},{"issue":"5","key":"12846_CR34","first-page":"1816","volume":"46","author":"M Wang","year":"2020","unstructured":"Wang M, Yu H, Wu R, Chen ZY, Hu Q, Zhang YF, Chen Z, Zhang Y, Gao S, Zhou G, Zhou GB (2020) Autophagy inhibition enhances the inhibitory effects of ursolic acid on lung cancer cells. Int J Mol Med 46(5):1816\u20131826","journal-title":"Int J Mol Med"},{"issue":"4","key":"12846_CR35","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.3892\/etm.2017.4965","volume":"14","author":"J Luo","year":"2017","unstructured":"Luo J, Hu YL, Wang H (2017) Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K\/AKT and NF-\u03baB signaling pathways in vitro. Exp Ther Med 14(4):3623\u20133631. https:\/\/doi.org\/10.3892\/etm.2017.4965","journal-title":"Exp Ther Med"},{"issue":"11","key":"12846_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113399","volume":"27","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhang P, Jiang H, Sun B, Luo H, Jia A (2022) Ursolic acid enhances the sensitivity of MCF-7 and MDA-MB-231 cells to epirubicin by modulating the autophagy pathway. Molecules 27(11):3399. https:\/\/doi.org\/10.3390\/molecules27113399","journal-title":"Molecules"},{"issue":"2\u20133","key":"12846_CR37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1006\/jsbi.2000.4254","volume":"129","author":"JD Robertson","year":"2000","unstructured":"Robertson JD, Orrenius S, Zhivotovsky B (2000) Review: nuclear events in apoptosis. J Struct Biol 129(2\u20133):346\u2013358. https:\/\/doi.org\/10.1006\/jsbi.2000.4254","journal-title":"J Struct Biol"},{"issue":"6","key":"12846_CR38","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10495-017-1353-7","volume":"22","author":"A Lewinska","year":"2017","unstructured":"Lewinska A, Adamczyk-Grochala J, Kwasniewicz E, Deregowska A, Wnuk M (2017) Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells. Apoptosis 22(6):800\u2013815. https:\/\/doi.org\/10.1007\/s10495-017-1353-7","journal-title":"Apoptosis"},{"issue":"1","key":"12846_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.20588","volume":"114","author":"PO Harmand","year":"2005","unstructured":"Harmand PO, Duval R, Delage C, Simon A (2005) Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int J Cancer 114(1):1\u201311. https:\/\/doi.org\/10.1002\/ijc.20588","journal-title":"Int J Cancer"},{"key":"12846_CR40","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s12272-011-0817-5","volume":"34","author":"KH Kim","year":"2011","unstructured":"Kim KH, Seo HS, Choi HS, Choi I, Shin YC, Ko SG (2011) Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Arch Pharm Res 34:1363\u20131372","journal-title":"Arch Pharm Res"},{"issue":"2","key":"12846_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1254\/jphs.14017fp","volume":"125","author":"Y Li","year":"2014","unstructured":"Li Y, Lu X, Qi H, Li X, Xiao X, Gao J (2014) Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and suppression of ERK1\/2 MAPK in HeLa cells. J Pharmacol Sci 125(2):202\u2013210. https:\/\/doi.org\/10.1254\/jphs.14017fp","journal-title":"J Pharmacol Sci"},{"key":"12846_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2025.100593","volume":"28","author":"S Singh","year":"2025","unstructured":"Singh S, Subudhi M, Suresh A, Sharma P (2025) Ursolic acid induces apoptosis and disrupts host-parasite interactions in Theileria annulata-infected cells. Int J Parasitol Drugs Drug Resist 28:100593","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"12846_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117351","volume":"319","author":"W Liu","year":"2024","unstructured":"Liu W, Kang S, Chen H, Bahetjan Y, Zhang J, Lu R, Zheng N, Yang G, Yang X (2024) A composition of ursolic acid derivatives from Ludwigia hyssopifolia induces apoptosis in throat cancer cells via the Akt\/mTOR and mitochondrial signaling pathways and by modulating endoplasmic reticulum stress. J Ethnopharmacol 319:117351","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"12846_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4062\/biomolther.2017.237","volume":"27","author":"CY Wang","year":"2019","unstructured":"Wang CY, Lin CS, Hua CH, Jou YJ, Liao CR, Chang YS, Wan L, Huang SH, Hour MJ, Lin CW (2019) Cis-3-O-p-hydroxycinnamoyl ursolic acid induced ROS-dependent p53-mediated mitochondrial apoptosis in oral cancer cells. Biomol Ther 27(1):54\u201362. https:\/\/doi.org\/10.4062\/biomolther.2017.237","journal-title":"Biomol Ther"},{"issue":"20","key":"12846_CR45","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1016\/j.bmc.2009.08.046","volume":"17","author":"HY Tu","year":"2009","unstructured":"Tu HY, Huang AM, Wei BL, Gan KH, Hour TC, Yang SC, Lin CN (2009) Ursolic acid derivatives induce cell cycle arrest and apoptosis in NTUB1 cells associated with reactive oxygen species. Bioorgan Med Chem 17(20):7265\u20137274","journal-title":"Bioorgan Med Chem"},{"issue":"12","key":"12846_CR46","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3390\/molecules21121640","volume":"21","author":"CC Wu","year":"2016","unstructured":"Wu CC, Huang YF, Hsieh CP, Chueh PJ, Chen YL (2016) Combined use of zoledronic acid augments ursolic acid-induced apoptosis in human osteosarcoma cells through enhanced oxidative stress and autophagy. Molecules 21(12):1640","journal-title":"Molecules"},{"key":"12846_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/srep05006","volume":"4","author":"J Wang","year":"2014","unstructured":"Wang J, Jiang Z, Xiang L, Li Y, Ou M, Yang X, Shao J, Lu Y, Lin L, Chen J, Dai Y, Jia L (2014) Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis. Sci Rep 4:5006. https:\/\/doi.org\/10.1038\/srep05006","journal-title":"Sci Rep"},{"issue":"14","key":"12846_CR48","first-page":"1915","volume":"123","author":"YX Yu","year":"2010","unstructured":"Yu YX, Gu ZL, Yin JL, Chou WH, Kwok CY, Qin ZH, Liang ZQ (2010) Ursolic acid induces human hepatoma cell line SMMC-7721 apoptosis via p53-dependent pathway. Chin Med J 123(14):1915\u20131923","journal-title":"Chin Med J"},{"key":"12846_CR49","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.fct.2013.09.024","volume":"62","author":"H Nam","year":"2013","unstructured":"Nam H, Kim MM (2013) Ursolic acid induces apoptosis of SW480 cells via p53 activation. Food Chem Toxicol 62:579\u2013583","journal-title":"Food Chem Toxicol"},{"key":"12846_CR50","doi-asserted-by":"publisher","unstructured":"Kour, J., Lone, B. A., Shah, N. ue-din, Ganai, B. A., Ali, M. N., & Akbar, S. (2024). Ameliorative Potential of Ursolic Acid Isolated from Morina coulteriana Royle Targeting P53 Gene Mutation Induced by Cyclophosphamide. Asian Pacific Journal of Cancer Biology, 9(4), 547\u2013552. https:\/\/doi.org\/10.31557\/apjcb.2024.9.4.547-552","DOI":"10.31557\/apjcb.2024.9.4.547-552"},{"issue":"6","key":"12846_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-025-02749-7","volume":"42","author":"B Wang","year":"2025","unstructured":"Wang B, Huang K, Xiao J, Tao Y, Luo J, Wu Y, Zhou S, He Y, He L (2025) Ursolic acid induces apoptosis in nasopharyngeal carcinoma cells through the P53 signaling pathway: a network pharmacology and experimental validation study. Med Oncol 42(6):1\u201314","journal-title":"Med Oncol"},{"issue":"1","key":"12846_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-025-04808-y","volume":"25","author":"R Zhang","year":"2025","unstructured":"Zhang R, Zhang Z, Xie L, Yu Z, Gao R, Zhang ZR, Zhang Y, Wei X, Chen Y, Jiao S, Gao Y, Guo JP (2025) In vitro analysis of the molecular mechanisms of ursolic acid against ovarian cancer. BMC Complement Med Ther 25(1):65","journal-title":"BMC Complement Med Ther"},{"key":"12846_CR53","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221111333","volume":"41","author":"X Cao","year":"2022","unstructured":"Cao X, He Q (2022) Ursolic acid inhibits proliferation, migration and invasion of human papillary thyroid carcinoma cells via CXCL12\/CXCR4\/CXCR7 axis through cancer-associated fibroblasts. Hum Exp Toxicol 41:9603271221111333. https:\/\/doi.org\/10.1177\/09603271221111333","journal-title":"Hum Exp Toxicol"},{"issue":"8","key":"12846_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082378","volume":"15","author":"W Tao","year":"2023","unstructured":"Tao W et al (2023) Ursolic acid alleviates cancer cachexia and prevents muscle wasting via activating SIRT1. Cancers 15(8):2378","journal-title":"Cancers"},{"key":"12846_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep14570","volume":"5","author":"SH Kim","year":"2015","unstructured":"Kim SH, Ryu HG, Lee J, Shin J, Harikishore A, Jung HY, Kim YS, Lyu HN, Oh E, Baek NI, Choi KY, Yoon HS, Kim KT (2015) Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells. Sci Rep 5:14570. https:\/\/doi.org\/10.1038\/srep14570","journal-title":"Sci Rep"},{"issue":"1","key":"12846_CR56","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/13880209.2020.1794013","volume":"58","author":"W Gou","year":"2020","unstructured":"Gou W, Luo N, Wei H, Wu H, Yu X, Duan Y, Bi C, Ning H, Hou W, Li Y (2020) Ursolic acid derivative UA232 evokes apoptosis of lung cancer cells induced by endoplasmic reticulum stress. Pharm Biol 58(1):707\u2013715. https:\/\/doi.org\/10.1080\/13880209.2020.1794013","journal-title":"Pharm Biol"},{"issue":"24","key":"12846_CR57","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1111\/bph.14793","volume":"176","author":"K Yang","year":"2019","unstructured":"Yang K, Chen Y, Zhou J, Ma L, Shan Y, Cheng X, Wang Y, Zhang Z, Ji X, Chen L, Dai H, Zhu B, Li C, Tao Z, Hu X, Yin W (2019) Ursolic acid promotes apoptosis and mediates transcriptional suppression of CT45A2 gene expression in non-small-cell lung carcinoma harbouring EGFR T790M mutations. Br J Pharmacol 176(24):4609\u20134624. https:\/\/doi.org\/10.1111\/bph.14793","journal-title":"Br J Pharmacol"},{"key":"12846_CR58","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.2147\/DDDT.S110505","volume":"10","author":"S Wu","year":"2016","unstructured":"Wu S, Zhang T, Du J (2016) Ursolic acid sensitizes cisplatin-resistant HepG2\/DDP cells to cisplatin via inhibiting Nrf2\/ARE pathway. Drug Des Devel Ther 10:3471\u20133481. https:\/\/doi.org\/10.2147\/DDDT.S110505","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"12846_CR59","first-page":"262","volume":"29","author":"ZY Li","year":"2021","unstructured":"Li ZY, Chen SY, Weng MH, Yen GC (2021) Ursolic acid restores sensitivity to gemcitabine through the RAGE\/NF-\u03baB\/MDR1 axis in pancreatic cancer cells and in a mouse xenograft model. J Food Drug Anal 29(2):262","journal-title":"J Food Drug Anal"},{"key":"12846_CR60","doi-asserted-by":"publisher","first-page":"8413","DOI":"10.2147\/CMAR.S264070","volume":"12","author":"Z Chen","year":"2020","unstructured":"Chen Z, Liu Q, Zhu Z, Xiang F, Zhang M, Wu R, Kang X (2020) Ursolic acid protects against proliferation and inflammatory response in LPS-treated gastric tumour model and cells by inhibiting NLRP3 inflammasome activation. Cancer Manag Res 12:8413\u20138424. https:\/\/doi.org\/10.2147\/CMAR.S264070","journal-title":"Cancer Manag Res"},{"issue":"1","key":"12846_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3892\/mmr.2022.12898","volume":"27","author":"D Hu","year":"2022","unstructured":"Hu D, Meng RY, Nguyen TV, Chai OH, Park BH, Lee JS, Kim SM (2022) Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway. Mol Med Rep 27(1):11","journal-title":"Mol Med Rep"},{"issue":"9","key":"12846_CR62","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1021\/acs.jafc.2c06775","volume":"71","author":"H Zhao","year":"2023","unstructured":"Zhao H et al (2023) Ursolic acid suppresses colorectal cancer by down-regulation of Wnt\/\u03b2-catenin signaling pathway activity. J Agric Food Chem 71(9):3981\u20133993","journal-title":"J Agric Food Chem"},{"issue":"2","key":"12846_CR63","doi-asserted-by":"publisher","DOI":"10.3892\/or.2023.8686","volume":"51","author":"M Zhang","year":"2024","unstructured":"Zhang M, Xiang F, Sun Y, Liu R, Li Q, Gu Q, Kang X, Wu R (2024) Ursolic acid inhibits the metastasis of colon cancer by downregulating ARL4C expression. Oncol Rep 51(2):27. https:\/\/doi.org\/10.3892\/or.2023.8686","journal-title":"Oncol Rep"},{"issue":"3","key":"12846_CR64","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.3892\/ol.2019.10604","volume":"18","author":"L Zhang","year":"2019","unstructured":"Zhang L, Cai QY, Liu J, Peng J, Chen YQ, Sferra TJ, Lin JM (2019) Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF-\u03b21\/ZEB1\/miR-200c signaling pathway. Oncol Lett 18(3):3274\u20133282. https:\/\/doi.org\/10.3892\/ol.2019.10604","journal-title":"Oncol Lett"},{"key":"12846_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.681425","volume":"11","author":"A Shen","year":"2021","unstructured":"Shen A, Wu M, Liu L, Chen Y, Chen X, Zhuang M, Xie Q, Cheng Y, Li J, Shen Z, Wei L, Chu J, Sferra TJ, Zhang X, Xu N, Li L, Peng J, Chen F (2021) Targeting NUFIP1 suppresses growth and induces senescence of colorectal cancer cells. Front Oncol 11:681425. https:\/\/doi.org\/10.3389\/fonc.2021.681425","journal-title":"Front Oncol"},{"issue":"4","key":"12846_CR66","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/molecules27041282","volume":"27","author":"L Zong","year":"2022","unstructured":"Zong L, Cheng G, Zhao J, Zhuang X, Zheng Z, Liu Z, Song F (2022) Inhibitory effect of ursolic acid on the migration and invasion of doxorubicin-resistant breast cancer. Molecules 27(4):1282","journal-title":"Molecules"},{"issue":"24","key":"12846_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244079","volume":"11","author":"DL Fogde","year":"2022","unstructured":"Fogde DL, Xavier CPR, Balnyt\u0117 K, Holland LKK, Stahl-Meyer K, Dinant C, Corcelle-Termeau E, Pereira-Wilson C, Maeda K, J\u00e4\u00e4ttel\u00e4 M (2022) Ursolic acid impairs cellular lipid homeostasis and lysosomal membrane integrity in breast carcinoma cells. Cells 11(24):4079. https:\/\/doi.org\/10.3390\/cells11244079","journal-title":"Cells"},{"key":"12846_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.745584","volume":"11","author":"S Wang","year":"2021","unstructured":"Wang S, Chang X, Zhang J, Li J, Wang N, Yang B, Pan B, Zheng Y, Wang X, Ou H, Wang Z (2021) Ursolic acid inhibits breast cancer metastasis by suppressing glycolytic metabolism via activating SP1\/Caveolin-1 signaling. Front Oncol 11:745584. https:\/\/doi.org\/10.3389\/fonc.2021.745584","journal-title":"Front Oncol"},{"issue":"7","key":"12846_CR69","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1080\/01635581.2013.810292","volume":"65","author":"Y Achiwa","year":"2013","unstructured":"Achiwa Y, Hasegawa K, Udagawa Y (2013) Effect of ursolic acid on MAPK in cyclin D1 signaling and RING-type E3 ligase (SCF E3s) in two endometrial cancer cell lines. Nutr Cancer 65(7):1026\u20131033. https:\/\/doi.org\/10.1080\/01635581.2013.810292","journal-title":"Nutr Cancer"},{"issue":"1","key":"12846_CR70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mc.23365","volume":"61","author":"S Li","year":"2022","unstructured":"Li S, Wu R, Wang L, Dina Kuo HC, Sargsyan D, Zheng X, Wang Y, Su X, Kong AN (2022) Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment\/prevention of human prostate cancer. Mol Carcinog 61(1):111\u2013121. https:\/\/doi.org\/10.1002\/mc.23365","journal-title":"Mol Carcinog"},{"issue":"8","key":"12846_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087414","volume":"24","author":"A Kornel","year":"2023","unstructured":"Kornel A, Nadile M, Retsidou MI, Sakellakis M, Gioti K, Beloukas A, Sze NSK, Klentrou P, Tsiani E (2023) Ursolic acid against prostate and urogenital cancers: a review of in vitro and in vivo studies. Int J Mol Sci 24(8):7414. https:\/\/doi.org\/10.3390\/ijms24087414","journal-title":"Int J Mol Sci"},{"issue":"4","key":"12846_CR72","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.3892\/ol.2016.5015","volume":"12","author":"WT Gai","year":"2016","unstructured":"Gai WT, Yu DP, Wang XS, Wang PT (2016) Anti-cancer effect of ursolic acid activates apoptosis through ROCK\/PTEN mediated mitochondrial translocation of cofilin-1 in prostate cancer. Oncol Lett 12(4):2880\u20132885. https:\/\/doi.org\/10.3892\/ol.2016.5015","journal-title":"Oncol Lett"},{"issue":"3","key":"12846_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032476","volume":"7","author":"MK Shanmugam","year":"2012","unstructured":"Shanmugam MK, Ong TH, Kumar AP, Lun CK, Ho PC, Wong PT, Hui KM, Sethi G (2012) Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. PLoS ONE 7(3):e32476. https:\/\/doi.org\/10.1371\/journal.pone.0032476","journal-title":"PLoS ONE"},{"issue":"19","key":"12846_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194767","volume":"20","author":"GH Kim","year":"2019","unstructured":"Kim GH, Kan SY, Kang H, Lee S, Ko HM, Kim JH, Lim JH (2019) Ursolic acid suppresses cholesterol biosynthesis and exerts anti-cancer effects in hepatocellular carcinoma cells. Int J Mol Sci 20(19):4767. https:\/\/doi.org\/10.3390\/ijms20194767","journal-title":"Int J Mol Sci"},{"issue":"11","key":"12846_CR75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.18632\/oncotarget.7537","volume":"7","author":"S Prasad","year":"2016","unstructured":"Prasad S, Yadav VR, Sung B, Gupta SC, Tyagi AK, Aggarwal BB (2016) Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment. Oncotarget 7(11):131","journal-title":"Oncotarget"},{"issue":"6","key":"12846_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27722","volume":"10","author":"B Hei","year":"2024","unstructured":"Hei B, Liu RE, Li M (2024) Ursolic acid inhibits glioblastoma through suppressing TGF\u03b2-mediated epithelial-mesenchymal transition (EMT) and angiogenesis. Heliyon 10(6):e27722. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27722","journal-title":"Heliyon"},{"issue":"5","key":"12846_CR77","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.3892\/or.2015.4213","volume":"34","author":"J Zhang","year":"2015","unstructured":"Zhang J, Wang W, Qian L, Zhang Q, Lai D, Qi C (2015) Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition. Oncol Rep 34(5):2375\u20132384. https:\/\/doi.org\/10.3892\/or.2015.4213","journal-title":"Oncol Rep"},{"issue":"4","key":"12846_CR78","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/jog.13919","volume":"45","author":"JL Guo","year":"2019","unstructured":"Guo JL, Han T, Bao L, Li XM, Ma JQ, Tang LP (2019) Ursolic acid promotes the apoptosis of cervical cancer cells by regulating endoplasmic reticulum stress. J Obstet Gynaecol Res 45(4):877\u2013881. https:\/\/doi.org\/10.1111\/jog.13919","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"12846_CR79","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1111\/j.1476-5381.2011.01684.x","volume":"165","author":"N Gao","year":"2012","unstructured":"Gao N, Cheng S, Budhraja A, Gao Z, Chen J, Liu EH, Huang C, Chen D, Yang Z, Liu Q, Li P, Shi X, Zhang Z (2012) Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway. Br J Pharmacol 165(6):1813\u20131826. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01684.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"12846_CR80","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bbamcr.2012.12.005","volume":"1833","author":"SW Shin","year":"2013","unstructured":"Shin SW, Park JW (2013) Ursolic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Biochim Biophys Acta 1833(3):723\u2013730. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.12.005","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"12846_CR81","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3892\/ijo.2013.2101","volume":"43","author":"J Lin","year":"2013","unstructured":"Lin J, Chen Y, Wei L, Hong Z, Sferra TJ, Peng J (2013) Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways. Int J Oncol 43(5):1666\u20131674. https:\/\/doi.org\/10.3892\/ijo.2013.2101","journal-title":"Int J Oncol"},{"key":"12846_CR82","doi-asserted-by":"publisher","first-page":"112481","DOI":"10.1016\/j.msec.2021.112481","volume":"131","author":"A L\u0151rincz","year":"2021","unstructured":"L\u0151rincz A, Mih\u00e1ly J, Wacha A, N\u00e9meth C, Besztercei B, Gyulav\u00e1ri P, Varga Z, Pet\u00e1k I, B\u00f3ta A (2021) Combination of multifunctional ursolic acid with kinase inhibitors for anti-cancer drug carrier vesicles. Mater Sci Eng C 131:112481. https:\/\/doi.org\/10.1016\/j.msec.2021.112481","journal-title":"Mater Sci Eng C"},{"key":"12846_CR83","doi-asserted-by":"crossref","unstructured":"Fajardo, J. B., Vianna, M. H., Ferreira, T. G., de O. Lemos, A. S., Souza, T. D. F., Campos, L. M., ... & Fabri, R. L. (2025). Enhanced Antitumor and Antibacterial Activities of Ursolic Acid through \u03b2-Cyclodextrin Inclusion Complexation. ACS omega, 10(13), 12906-12916","DOI":"10.1021\/acsomega.4c08337"},{"issue":"20","key":"12846_CR84","doi-asserted-by":"publisher","first-page":"17010","DOI":"10.1021\/jacs.5c01214","volume":"147","author":"M Lin","year":"2025","unstructured":"Lin M, Liu D, Gong Y, Shu L, Wang H, Zhang G, Li J, Gao Z, Sun J, Chen X (2025) Bioactive assembly cofactor-assisted ursolic acid helix for enhanced anticancer efficacy viain situ virus-like transition. J Am Chem Soc 147(20):17010\u201317021. https:\/\/doi.org\/10.1021\/jacs.5c01214","journal-title":"J Am Chem Soc"},{"issue":"5","key":"12846_CR85","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/acsanm.3c06161","volume":"7","author":"P Payomhom","year":"2024","unstructured":"Payomhom P, Panyain N, Sakonsinsiri C, Wongtrakoongate P, Lertsuwan K, Pissuwan D, Katewongsa KP (2024) Chitosan-coated poly (lactic-co-glycolic acid) nanoparticles loaded with ursolic acid for breast cancer therapy. ACS Appl Nano Mater 7(5):5383\u20135395. https:\/\/doi.org\/10.1021\/acsanm.3c06161","journal-title":"ACS Appl Nano Mater"},{"key":"12846_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/srep30782","volume":"6","author":"H Jin","year":"2016","unstructured":"Jin H, Pi J, Yang F, Jiang J, Wang X, Bai H, Shao M, Huang L, Zhu H, Yang P, Li L, Li T, Cai J, Chen ZW (2016) Folate-chitosan nanoparticles loaded with ursolic acid confer anti-breast cancer activities in vitro and in vivo. Sci Rep 6:30782. https:\/\/doi.org\/10.1038\/srep30782","journal-title":"Sci Rep"},{"issue":"17","key":"12846_CR87","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.3390\/ma14174917","volume":"14","author":"A Markowski","year":"2021","unstructured":"Markowski A, Migda\u0142 P, Zygmunt A, Zaremba-Czogalla M, Gubernator J (2021) Evaluation of the in vitro cytotoxic activity of ursolic acid PLGA nanoparticles against pancreatic ductal adenocarcinoma cell lines. Materials 14(17):4917. https:\/\/doi.org\/10.3390\/ma14174917","journal-title":"Materials"},{"issue":"15","key":"12846_CR88","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1039\/D2TB02328H","volume":"11","author":"F Xu","year":"2023","unstructured":"Xu F, Li M, Que Z, Su M, Yao W, Zhang Y, Luo B, Li Y, Zhang Z, Tian J (2023) Combined chemo-immuno-photothermal therapy based on ursolic acid\/astragaloside IV-loaded hyaluronic acid-modified polydopamine nanomedicine inhibiting the growth and metastasis of non-small cell lung cancer. J Mater Chem B 11(15):3453\u20133472","journal-title":"J Mater Chem B"},{"issue":"2","key":"12846_CR91","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1021\/acsomega.0c04350","volume":"6","author":"Y Liu","year":"2021","unstructured":"Liu Y, Kong T, Yang Z, Zhang Y, Lei J, Zhao P (2021) Self-assembled folic acid-targeted pectin-multi-arm polyethylene glycol nanoparticles for tumor intracellular chemotherapy. ACS Omega 6(2):1223\u20131234. https:\/\/doi.org\/10.1021\/acsomega.0c04350","journal-title":"ACS Omega"},{"issue":"6","key":"12846_CR92","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1021\/acs.molpharmaceut.8b00444","volume":"15","author":"L Fan","year":"2018","unstructured":"Fan L, Zhang B, Xu A, Shen Z, Guo Y, Zhao R, Yao H, Shao JW (2018) Carrier-free, pure nanodrug formed by the self-assembly of an anticancer drug for cancer immune therapy. Mol Pharm 15(6):2466\u20132478. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00444","journal-title":"Mol Pharm"},{"key":"12846_CR93","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.2147\/IJN.S77125","volume":"10","author":"H Zhang","year":"2015","unstructured":"Zhang H, Zheng D, Ding J, Xu H, Li X, Sun W (2015) Efficient delivery of ursolic acid by poly(N-vinylpyrrolidone)-block-poly (\u03b5-caprolactone) nanoparticles for inhibiting the growth of hepatocellular carcinoma in vitro and in vivo. Int J Nanomed 10:1909\u20131920. https:\/\/doi.org\/10.2147\/IJN.S77125","journal-title":"Int J Nanomed"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12846-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12846-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12846-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:21:25Z","timestamp":1792160485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12846-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12846"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12846-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"13 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1736"}}